MYD88 and diffuse large B-cell lymphoma: Mutations in MYD88, CD79B, and BCL10 are more frequently detected (~15–25%) in ABC-transformed cases, whereas 2p16 (REL) amplification is predominantly observed in GCB-transformed cases, consistent with patterns reported in DLBCL [107,121,127,128].